EP1261735A4 - Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir) - Google Patents

Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir)

Info

Publication number
EP1261735A4
EP1261735A4 EP01905085A EP01905085A EP1261735A4 EP 1261735 A4 EP1261735 A4 EP 1261735A4 EP 01905085 A EP01905085 A EP 01905085A EP 01905085 A EP01905085 A EP 01905085A EP 1261735 A4 EP1261735 A4 EP 1261735A4
Authority
EP
European Patent Office
Prior art keywords
lir
polynucleotides
polypeptides
methods
immunoglobulin receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01905085A
Other languages
German (de)
English (en)
Other versions
EP1261735A2 (fr
Inventor
Bryan J Boyle
Chiauyun Kuo
Nancy K Mize
Dana A Haley
Matthew C Arterburn
Y Tom Tang
Ping Zhou
Chenghua Liu
Vinod Asundi
Radoje T Drmanac
George Yeung
Servando Palencia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1261735A2 publication Critical patent/EP1261735A2/fr
Publication of EP1261735A4 publication Critical patent/EP1261735A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP01905085A 2000-01-25 2001-01-25 Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir) Withdrawn EP1261735A4 (fr)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US49140400A 2000-01-25 2000-01-25
US491404 2000-01-25
US49691400A 2000-02-03 2000-02-03
US496914 2000-02-03
US51970500A 2000-03-07 2000-03-07
US519705 2000-03-07
US56087500A 2000-04-27 2000-04-27
US560875 2000-04-27
US524454 2000-05-19
US64261000A 2000-08-17 2000-08-17
US642610 2000-08-17
US75151800A 2000-12-29 2000-12-29
US751518 2000-12-29
PCT/US2001/002570 WO2001055335A2 (fr) 2000-01-25 2001-01-25 Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir)

Publications (2)

Publication Number Publication Date
EP1261735A2 EP1261735A2 (fr) 2002-12-04
EP1261735A4 true EP1261735A4 (fr) 2005-04-06

Family

ID=46397760

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01905085A Withdrawn EP1261735A4 (fr) 2000-01-25 2001-01-25 Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir)

Country Status (4)

Country Link
EP (1) EP1261735A4 (fr)
AU (2) AU3300301A (fr)
CA (1) CA2398251A1 (fr)
WO (1) WO2001055335A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050238643A1 (en) * 2001-11-14 2005-10-27 Arm Jonathan P Modulation of lir function to treat rheumatoid arthritis
AU2002952993A0 (en) * 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
EP1712563A4 (fr) * 2004-01-27 2008-05-28 Medical & Biol Lab Co Ltd Methode pour isoler des monocytes
WO2007037430A1 (fr) * 2005-09-29 2007-04-05 Eisai R & D Management Co., Ltd. Molécule d'adhésion de lymphocyte t et anticorps dirigé contre la molécule
JP5947727B2 (ja) 2010-01-20 2016-07-06 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 抗ｉｌｔ５抗体およびｉｌｔ５結合抗体断片による免疫調節
EP2525813B1 (fr) 2010-01-20 2017-01-04 Merck Sharp & Dohme Corp. Anticorps anti-ilt5 et fragments d'anticorps se liant à ilt5
RU2017114801A (ru) 2014-10-01 2018-11-06 Плант Хелс Кэар, Инк. Элиситорные пептиды, имеющие разрушенный бокс гиперчувствительного ответа, и их применение
US10856546B2 (en) 2014-10-01 2020-12-08 Plant Health Care, Inc. Hypersensitive response elicitor peptides and use thereof
US10793608B2 (en) 2016-04-06 2020-10-06 Plant Health Care, Inc. Hypersensitive response elicitor-derived peptides and use thereof
BR112018069945A2 (pt) 2016-04-06 2019-02-05 Plant Health Care Inc micróbios benéficos para distribuição de peptídeos ou proteínas efetoras e uso dos mesmos

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998031806A2 (fr) * 1997-01-21 1998-07-23 Human Genome Sciences, Inc. RECEPTEURS Fc ET POLYPEPTIDES
WO1998045435A2 (fr) * 1997-04-10 1998-10-15 Genetics Institute, Inc. MARQUEURS SECRETES DE SEQUENCE EXPRIMEE (sEST)
WO1998048017A1 (fr) * 1997-04-24 1998-10-29 Immunex Corporation Famille d'immunoregulateur appeles recepteurs des leucocytes, ressemblant a l'immunoglobuline
EP0897981A1 (fr) * 1997-08-19 1999-02-24 Smithkline Beecham PIGR-1, un membre de la superfamille des gènes des immunoglobulines
EP0905237A2 (fr) * 1997-08-25 1999-03-31 Smithkline Beecham Corporation PIGR-2 appartenant au sous-ordre des immunoglobulines
WO2000047602A1 (fr) * 1999-02-10 2000-08-17 Human Genome Sciences, Inc. 33 proteines humaines secretees
WO2001000673A1 (fr) * 1999-06-30 2001-01-04 Millennium Pharmaceuticals, Inc. Proteines associees aux membranes et secretees, et leurs utilisations
WO2001012662A2 (fr) * 1999-08-17 2001-02-22 Incyte Genomics, Inc. Proteines associees a la membrane

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078962A1 (fr) * 1999-06-18 2000-12-28 Immunex Corporation Recepteur de surface de leucocyte (lsr), un adnc de la superfamille des ig exprime dans les leucocytes humains

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998031806A2 (fr) * 1997-01-21 1998-07-23 Human Genome Sciences, Inc. RECEPTEURS Fc ET POLYPEPTIDES
WO1998045435A2 (fr) * 1997-04-10 1998-10-15 Genetics Institute, Inc. MARQUEURS SECRETES DE SEQUENCE EXPRIMEE (sEST)
WO1998048017A1 (fr) * 1997-04-24 1998-10-29 Immunex Corporation Famille d'immunoregulateur appeles recepteurs des leucocytes, ressemblant a l'immunoglobuline
EP0897981A1 (fr) * 1997-08-19 1999-02-24 Smithkline Beecham PIGR-1, un membre de la superfamille des gènes des immunoglobulines
EP0905237A2 (fr) * 1997-08-25 1999-03-31 Smithkline Beecham Corporation PIGR-2 appartenant au sous-ordre des immunoglobulines
WO2000047602A1 (fr) * 1999-02-10 2000-08-17 Human Genome Sciences, Inc. 33 proteines humaines secretees
WO2001000673A1 (fr) * 1999-06-30 2001-01-04 Millennium Pharmaceuticals, Inc. Proteines associees aux membranes et secretees, et leurs utilisations
WO2001012662A2 (fr) * 1999-08-17 2001-02-22 Incyte Genomics, Inc. Proteines associees a la membrane

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
COLONNA M ET AL: "A NOVEL FAMILY OF IG-LIKE RECEPTORS FOR HLA CLASS I MOLECULES THAT MODULATE FUNCTION OF LYMPHOID AND MYELOID CELLS", JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL, US, vol. 66, no. 3, September 1999 (1999-09-01), pages 375 - 381, XP008031825, ISSN: 0741-5400 *
DATABASE EMBL EBI; 14 December 1999 (1999-12-14), BIRREN B., NUSBAUM C., LANDER E.: "Homo sapiens chromosome 17, clone RP11-452I5, complete sequence.", XP002302980, Database accession no. AC016888 *
DATABASE EMBL EBI; 26 September 1996 (1996-09-26), TOYABE S.: "Homo sapiens mRNA for CD89_U11, complete cds.", XP002302968, Database accession no. D87855 *
DATABASE GENEBANK NCBI; 1 January 1997 (1997-01-01), ROJO, S. ET AL.: "Human putative inhibitory receptor mRNA partial cds.", XP002302966, Database accession no. U70665 *
DATABASE Geneseq DERWENT; 27 April 1999 (1999-04-27), JACOBS K. ET AL. (GENETICS INST INC.): "EST clone O47.", XP002302981, Database accession no. AAV86215 *
DATABASE UniProt 1 October 1996 (1996-10-01), JACKSON D.G. ET AL.: "CMRF-35A antigen precursor (CMRF-35)", XP002302967, Database accession no. Q08708 *
JACKSON D G ET AL: "MOLECULAR CLONING OF A NOVEL MEMBER OF THE IMMUNOGLOBULIN GENE SUPERFAMILY HOMOLOGOUS TO THE POLYMERIC IMMUNOGLOBULIN RECEPTOR", EUROPEAN JOURNAL OF IMMUNOLOGY, WEINHEIM, DE, vol. 22, no. 5, 1992, pages 1157 - 1163, XP000972369, ISSN: 0014-2980 *
ROJO S ET AL: "Type I transmembrane receptor with inhibitory function in mouse mast cells and NK cells.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 1 JAN 1997, vol. 158, no. 1, 1 January 1997 (1997-01-01), pages 9 - 12, XP002074918, ISSN: 0022-1767 *
See also references of WO0155335A3 *

Also Published As

Publication number Publication date
WO2001055335A2 (fr) 2001-08-02
AU3300301A (en) 2001-08-07
AU2001233003B2 (en) 2006-02-09
CA2398251A1 (fr) 2001-08-02
WO2001055335A3 (fr) 2002-03-07
EP1261735A2 (fr) 2002-12-04

Similar Documents

Publication Publication Date Title
EP1250346A4 (fr) Procedes et elements ayant trait a des polypeptides et des polynucleotides de type recepteurs couples a une proteine g
AU8743001A (en) Moraxella polypeptides and corresponding dna fragments and uses thereof
AU3300301A (en) Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
EP1252333A4 (fr) Procedes et substances relatifs a des polypeptides de type cd84 et a des polynucleotides
IL136696A0 (en) Sigirr dna and polypeptides
EP1254266A4 (fr) Methodes et materiaux en rapport avec des polypeptides et de polynucleotides de type alpha-2-macroglobuline
EP1254269A4 (fr) Procedes et matieres lies aux polypeptides et aux polynucleotides du type molecule de guidage neuronal (du type ngm)
AU2002253816A1 (en) Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
IL137493A0 (en) Svph3-13 and spvh3-17 dna and polypeptides
AU3486501A (en) Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
AU2002360460A8 (en) Methods and materials relating to novel polypeptides and polynucleotides
EP1365801A4 (fr) Methodes et materiels se rapportant a des polypeptides et a des polynucleotides apparentes a la fibuline
EP1261736A4 (fr) Methodes et materiaux associes a des polypeptides et des polynucleotides du type facteur-1 des preadipocytes (du type pref-1)
EP1254265A4 (fr) Methodes et materiaux concernant des polypeptides et des polynucleotides du type metallocarboxypeptidase
AU2002359351A8 (en) Methods and materials relating to prokineticin-like polypeptides and polynucleotides
EP1240178A4 (fr) Procedes et substances relatifs a des polypeptides de type prothrombinase et a des polynucleotides
EP1212407A4 (fr) Polynucleotides, polypeptides, et anticorps de la superfamille des immunoglobulines
AU1933401A (en) Cytokine receptor-like polynucleotides, polypeptides, and antibodies
EP1248801A4 (fr) Polynucleotides, polypeptides et anticorps humains
AU2001233293A1 (en) Methods and materials relating to scavenger receptor-like polypeptides and polynucleotides
EP1276902A4 (fr) Procedes et substances relatifs a des polypeptides de type antigene carcino-embryonnaire (cea) et a des polynucleotides
EP1409715A4 (fr) Procedes et materiaux concernant des polypeptides et des polynucleotides du type neurotrimin
AUPQ645700A0 (en) Novel polypeptides and polynucleotides and methods of using them
AU2001232971A1 (en) Methods and materials relating to immunoglobulin domain-containing polypeptides and polynucleotides
EP1242580A4 (fr) Procedes et substances relatifs a des polypeptides de type semaphorine et a des polynucleotides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020826

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: KUO, CHIAUYUN

Inventor name: LIU, CHENGHUA

Inventor name: ARTERBURN, MATTHEW, C.

Inventor name: ZHOU, PING

Inventor name: MIZE, NANCY, K.

Inventor name: TANG, Y., TOM

Inventor name: HALEY, DANA, A.

Inventor name: BOYLE, BRYAN, J.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07H 21/02 B

Ipc: 7C 12Q 1/68 A

Ipc: 7C 07K 14/705 B

Ipc: 7A 61K 38/00 B

A4 Supplementary search report drawn up and despatched

Effective date: 20050221

17Q First examination report despatched

Effective date: 20050620

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20081008